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Abstract
Background: Choline is a new PET tracer that is useful for the detection of malignant tumor. Choline is a
precursor of the biosynthesis of phosphatidylcholine, a major phospholipid in the cell membrane of eukaryotic
cells. Malignant tumors have an elevated level of phosphatidylcholine in cell membrane. Thus, choline is a marker
of tumor malignancy.
Method: The patient was a 51-year-old man with repeated recurrent hemangiopericytoma in the skull base. We
performed Choline-PET in this patient after various treatments and compared findings with those of FDG-PET.
Results: Choline accumulated in this tumor, but FDG did not accumulate. We diagnosed this tumor as residual
hemangiopericytoma and performed the resection of the residual tumor. FDG-PET is not appropriate for skull base
tumor detection because uptake in the brain is very strong.
Conclusion: We emphasize the usefulness of Choline-PET for the detection of residual hemangiopericytoma in the
skull base after various treatments, compared with FDG-PET.
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Background
Positron emission tomography (PET) has been success-
fully used for the diagnosis of head and neck cancer and
18-fluorodeoxyglucose (FDG) is the most commonly
used PET tracer and FDG-PET offers the most effective-
ness for imaging various tumors. However, this technique
is not appropriate for skull base tumor detection because
FDG uptake in the brain is very strong. Recently 11 C-
choline was developed as a new PET tracer. Here we
report the effectiveness of this tracer for PET imaging of
residual hemangiopericytoma in the skull base. Heman-
giopericytoma is a very rare tumor in the head and neck
region. This tumor sometimes relapse in the base of
skull. Repeated surgeries could cause severe postopera-
tive complications. Therefore, accurate diagnosis of
recurrent tumor is strongly required now.
Case report
A 51-years-old Japanese man presented with a tumor in
the right temple and underwent resection of the tumor at
a medical college hospital in 1979. The histological diag-
nosis was hemangiopericytoma. Thereafter, he demon-
strated local recurrence many times, underwent resection
5 times and embolization was performed 2 times. Despite
these treatments, this tumor relapsed in the temple again
and was treated by irradiation (total 61.8 Gy) in Novem-
ber 2002. However, the tumor appeared to persist and
multiple lung metastases were detected. After 4 months,
he consulted our hospital for their treatment. On the first
medical examination at our hospital, we evaluated the
skull base tumor with MRI (Figure 1) and lung metastasis
with chest-CT. Because lung metastasis remained stable,
we performed Choline-PET and compared findings to
those of FDG-PET. Choline accumulated in the tip of the
right temporal lobe (SUV max 4.0) but FDG-PET could
not detect in the tumor because it accumulated strongly
throughout the whole brain without demonstrating the
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via the right external carotid artery demonstrated the
lesion strongly (Figure 3). Based on these examinations,
we diagnosed this lesion as residual hemangiopericytoma.
Then he underwent resection of the residual skull base
tumor in February 2004. First, we incised the coronary
line at the front of the head, and tried to approach this
tumor via right temporal craniotomy without facial inci-
sion. We resected completely the tumor together with a
part of dura because of dural invasion. The tumor
showed diffuse invasion of tissue around the mass lesion.
We reconstructed the skull base by galeal flap. In addi-
tion, we plugged the dead space after tumor resection
with abdominal fat tissue (Figure 4). There were no com-
plications postoperatively. This tumor demonstrated
abundant blood vessels and was composed of round or
spindle-shaped cells, including dilated staghorn-shaped
vessels (Figure 5). Immunohistochemically, expressions
of Vimentin and CD34(+) in cancer cells were positive
on immunostaning, while these of S-100 protein and
cytokeratin were negative(Figure 5). This histological
diagnosis was recurrent hemangiopericytoma. The
patient demonstrated a favorable postoperative course
and was discharged from our hospital on March 2004.
To date, we have not detected any recurrence in the
skullbase for 7 years postoperatively but lung metastases
increased gradually. Currently, he can work as well as he
could before onset of the disease.
Discussion
FDG-PET is not appropriate for skull base tumor detec-
tion or evaluation of recurrence because FDG uptake
throughout the brain is very strong. We used Choline-
PET, which was developed by Hara et all [1]. Choline is
a precursor of the biosynthesis of phosphatidylcholine,
which is a major phospholipid in the cell membrane of
eukaryotic cell. Malignant tumors have an elevated level
of phosphatidylcholine in their cell membranes. Thus,
choline is a marker of malignant tumor. Choline has
also a tendency to accumulate significantly in the liver,
kidney and spleen as well as the pancreas. Therefore
Choline-PET would not be useful in the upper abdo-
men. The features of Choline-PET include a shorter
examination period and lower uptake in the muscle and
brain than those PET with other tracers. Choline-PET
has been reported to be highly effective in imaging lung
cancer [2], brain tumors [3], prostate cancer [4] and
esophageal cancer [5]. There is a similarity between
skull base tumors and brain tumors. Thus, we per-
formed Choline-PET to malignant skull base tumor in
this case, although there were no reports describing
Choline-PET for head and neck tumor. In the future, we
will further investigate the usefulness of Choline-PET in
head and neck tumor patients in comparison with that
of FDG-PET in our hospital. Herein, present the first
report of recurrence of hemangiopericytoma demon-
strated by Choline-PET but not FDG-PET.
Figure 1 MRI findings (axial section and coronal section): The tumor (arrow) in the right temple showed low signal intensity on T1
weighted image (left) and enhanced by the contrast medium. (right).
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Page 2 of 5Figure 2 Result of PET study (left side:Choline-PET, right side: FDG-PET). Choline-PET (left side) showed the recurrent tumor in the tip of
the right temporal lobe (arrow) but FDG-PET (right side)could not detect the tumor. SUV max 4.
Figure 3 Angiography findings: Lateral and Frontal view of right external carotid artery angiography showed demonstrated the lesion
strongly.
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Zimmermann [6], which was first described by Stout and
Murray [7] in 1942. On histopathologic examination, the
tumor is characterized by a proliferation of oval and spin-
dle-shaped pericytic cells. The largest series was pub-
lished by Enzinger and Smith [8] and analyzed 106 cases
of hemangiopericytoma and 16% of these patients had
lesions in the head and neck region. The first choice of
treatment for hemangiopericytoma is wide surgical exci-
sion. Surgical excision is the preferred treatment, but
recurrence and metastasis can subsequently occur in up
to 50% of cases [9]. On first diagnosis, it is difficult to dis-
tinguish between benign and malignant forms. Recur-
rence may develop after a prolonged disease-free interval,
which stresses the need for long-term follow-up. There-
fore, we should detect recurrence as early as possible,
then resect the recurrence completely without causing
postoperative dysfunction.
We were able to diagnose residual hemangiopericy-
toma with Choline-PET after radiation therapy and could
completely resect this tumor safely. Although the lung
metastases have slightly increased after the treatment, the
Figure 4 Operative findings. The tumor was completely resected together with a part of dura from the right temple (right). The skull base was
reconstructed by galeal flap and the dead space was plugged with abdominal fat tissue (left).
Figure 5 Pathologic finding: a: This tumor was composed of round or spindle-shaped cells, including dilated staghorn-shaped vessels
(H-E × 200). b: Immunohistochemical staining of Vimentin showed positive expression in cancer cells. c: Expressions of CD34(+) in cancer cells
were positive on immunostaning.
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repeatedly recurrent case, therefore the patient should be
carefully followed.
Conclusion
We emphasize the usefulness of Choline-PET for the
detection of residual hemangiopericytoma in the skull
base after various treatments, compared with FDG-PET.
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